相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)
Fabrizio Tabbo et al.
CANCER TREATMENT REVIEWS (2022)
BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies
Corrado Zengarini et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)
Selection Strategies and Practical Application of BRAF V600E-Mutated Non-Small Cell Lung Carcinoma
Inwoo Hwang et al.
CANCER RESEARCH AND TREATMENT (2022)
Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions
Mariona Riudavets et al.
LUNG CANCER (2022)
BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
Ningning Yan et al.
FRONTIERS IN ONCOLOGY (2022)
Usefulness of BRAF VE1 immunohistochemistry in non-small cell lung cancers: a multi-institutional study by 15 pathologists in Korea
Sunhee Chang et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2022)
Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database
Jeff Owsley et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations
J. Mazieres et al.
ANNALS OF ONCOLOGY (2020)
Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France)
Veronique Hofman et al.
LUNG CANCER (2020)
Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
Ho Cheol Kim et al.
ONCOTARGETS AND THERAPY (2019)
Validation of Immunohistochemistry for the Detection of BRAF V600E-Mutated Lung Adenocarcinomas
Chien-Hung Gow et al.
CANCERS (2019)
BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall
Alessandro Leonetti et al.
CANCER TREATMENT REVIEWS (2018)
Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
Claire Tissot et al.
LUNG CANCER (2016)
Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations
T. Kinno et al.
ANNALS OF ONCOLOGY (2014)
BRAF-mutations in non-small cell lung cancer
Odd Terje Brustugun et al.
LUNG CANCER (2014)
Detection of BRAF V600E Mutation With Thyroid Tissue Using Pyrosequencing Comparison With PNA-Clamping and Real-Time PCR
Seong-Ho Kang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients
M. Ilie et al.
ANNALS OF ONCOLOGY (2013)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Harboring BRAF Mutations
Antonio Marchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
Paul K. Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2011)
Differential regulation and properties of MAPKs
M. Raman et al.
ONCOGENE (2007)